Stereotactic body radiation therapy for early-stage hepatocellular carcinoma – a systematic review on outcome

References

• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.
   PubMed Web of Science ®Google Scholar
• Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018;391:1301–1314.
   PubMed Web of Science ®Google Scholar
• Kamangar F, Dores G, Anderson W. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. JCO. 2006;24:2137–2150.
   PubMed Web of Science ®Google Scholar
• Kinoshita A, Onoda H, Fushiya N, et al. Staging systems for hepatocellular carcinoma: current status and future perspectives. WJH. 2015;7:406–424.
   PubMedGoogle Scholar
• Llovet J, Brú C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 1999;19:329–338.
   PubMed Web of Science ®Google Scholar
• Dawson B, Hashem S, Bujold A. Stereotactic body radiation therapy for hepatocellular carcinoma. Am Soc Clin Oncol Educ Book. 2012;118:261–264.
   PubMedGoogle Scholar
• Spychalski P, Kobiela J, Antoszewska M, et al. Patient specific outcomes of charged particle therapy for hepatocellular carcinoma – a systematic review and quantitative analysis. Radiother Oncol. 2019;132:127–134.
   PubMed Web of Science ®Google Scholar
• Kobiela J, Spychalski P, Marvaso G, et al. Ablative stereotactic radiotherapy for oligometastatic colorectal cancer: systematic review. Crit Rev Oncol Hematol. 2018;129:91–101.
   PubMed Web of Science ®Google Scholar
• Onal C, Guler O, Yildirim B. Treatment outcomes of breast cancer liver metastasis treated with stereotactic body radiotherapy. Breast. 2018; 42:150–156.
   PubMed Web of Science ®Google Scholar
• Scorsetti M, Comito T, Clerici E, et al. Phase II trial on SBRT for unresectable liver metastases: long-term outcome and prognostic factors of survival after 5 years of follow-up. Radiat Oncol. 2018;13:234.
   PubMed Web of Science ®Google Scholar
• Kreinbrink P, Blumenfeld P, Tolekidis G, et al. Lung stereotactic body radiation therapy (SBRT) for early-stage non-small cell lung cancer in the very elderly (≥80 years old): extremely safe and effective. J Geriatr Oncol. 2017;8:351–355.
   PubMed Web of Science ®Google Scholar
• Rim C, Seong J. Application of radiotherapy for hepatocellular carcinoma in current clinical practice guidelines. Radiat Oncol J. 2016;34:160–167.
   PubMed Web of Science ®Google Scholar
• Ohri N, Dawson L, Krishnan S, et al. Radiotherapy for hepatocellular carcinoma: new indications and directions for future study. J Natl Cancer Inst. 2016;108:djw133.
   PubMedGoogle Scholar
• Kim J, Seong J, Lee I, et al. Phase I dose-escalation study of helical intensity-modulated radiotherapy-based stereotactic body radiotherapy for hepatocellular carcinoma. Oncotarget. 2016;7:40756–40766.
   PubMedGoogle Scholar
• Takeda A, Sanuki N, Tsurugai Y, et al. Phase 2 study of stereotactic body radiotherapy and optional transarterial chemoembolization for solitary hepatocellular carcinoma not amenable to resection and radiofrequency ablation. Cancer. 2016;122:2041–2049.
   PubMed Web of Science ®Google Scholar
• Galle PR, Forner A, Llovet JM, et al. EASL Clinical Practice Guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69:182–236.
   PubMed Web of Science ®Google Scholar
• Vitale A, Burra P, Frigo AC, et al. Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study. J Hepatol. 2015;62:617–624.
   PubMed Web of Science ®Google Scholar
• Pan CC, Kavanagh BD, Dawson L, et al. Radiation-associated liver injury. Int J Radiat Oncol Biol Phys. 2010;76:94–100.
   PubMed Web of Science ®Google Scholar
• Carvajal C, Navarro-Martin A, Cacicedo J, et al. Stereotactic body radiotherapy for colorectal lung oligometastases: preliminary single-institution results. J BUON. 2015;20:158–165.
   PubMed Web of Science ®Google Scholar
• Shiba S, Abe T, Shibuya K, et al. Carbon ion radiotherapy for 80 years or older patients with hepatocellular carcinoma. BMC Cancer. 2017;17:721.
   PubMed Web of Science ®Google Scholar
• Lencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis. 2010;30:52–60.
   PubMed Web of Science ®Google Scholar
• Tirkes T, Hollar MA, Tann Dom,   et al. RECIST mRECIST Choi and PERSIST criteria for tumour assessment. 2013.
   Google Scholar
• Park J, Yoon SM, Lim S, et al. Two-week schedule of hypofractionated radiotherapy as a local salvage treatment for small hepatocellular carcinoma. J Gastroenterol Hepatol. 2013;28:1638–1642.
   PubMed Web of Science ®Google Scholar
• Huertas A, Baumann AS, Saunier-Kubs F, et al. Stereotactic body radiation therapy as an ablative treatment for inoperable hepatocellular carcinoma. Radiother Oncol. 2015;115:211–216.
   PubMed Web of Science ®Google Scholar
• Wahl DR, Stenmark MH, Tao Y, et al. Outcomes after stereotactic body radiotherapy or radiofrequency ablation for hepatocellular carcinoma. J Clin Oncol. 2016;34:452–459.
   PubMed Web of Science ®Google Scholar
• Moore A, Cohen-Naftaly M, Tobar A, et al. Stereotactic body radiation therapy (SBRT) for definitive treatment and as a bridge to liver transplantation in early stage inoperable hepatocellular carcinoma. Radiat Oncol. 2017;12:4–11.
   PubMed Web of Science ®Google Scholar
• Jeong Y, Cho B, Park JH, et al. Stereotactic body radiation therapy using respiratory-gated volumetric-modulated arc therapy technique for small hepatocellular carcinoma. Liver Cancer. 2018;4:201.
   Google Scholar
• Shiozawa K, Watanabe M, Ikehara T, et al. Comparison of percutaneous radiofrequency ablation and CyberKnife ® for initial solitary hepatocellular carcinoma: a pilot study. WJG. 2015;21:13490.
   PubMed Web of Science ®Google Scholar
• Kimura T, Aikata H, Takahashi S, et al. Stereotactic body radiotherapy for patients with small hepatocellular carcinoma ineligible for resection or ablation therapies. Hepatol Res. 2015;45:378–386.
   PubMed Web of Science ®Google Scholar
• Hasan S, Thai N, Uemura T, et al. Hepatocellular carcinoma with child Pugh-A Cirrhosis treated with stereotactic body radiotherapy. WJGS. 2017;9:256–263.
   Web of Science ®Google Scholar
• Yoon SM, Lim YS, Park MJ, et al. Stereotactic body radiation therapy as an alternative treatment for small hepatocellular carcinoma. PLoS One. 2013;8:e79854.
   PubMed Web of Science ®Google Scholar
• Zeng ZC, Seong J, Yoon SM, et al. Consensus on stereotactic body radiation therapy for small-sized hepatocellular carcinoma at the 7th Asia-Pacific Primary Liver Cancer Expert Meeting. Liver Cancer. 2017;6:264–274.
   PubMed Web of Science ®Google Scholar
• Garancini M, Nespoli S, Romano F, et al. Surgical management of hepatocellular carcinoma within and beyond BCLC indications in a middle volume center. J Visc Surg. 2018;155:275–282.
   PubMed Web of Science ®Google Scholar
• Chen MS, Li JQ, Zheng Y, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg. 2006;243:321–328.
   PubMed Web of Science ®Google Scholar
• Lee DH, Lee JM, Lee JY, et al. Radiofrequency ablation of hepatocellular carcinoma as first-line treatment: long-term results and prognostic factors in 162 patients with cirrhosis. Radiology. 2014;270:900–909.
   PubMed Web of Science ®Google Scholar
• Shibata T, Isoda H, Hirokawa Y, et al. Small hepatocellular carcinoma: is radiofrequency ablation combined with transcatheter arterial chemoembolization more effective than radiofrequency ablation alone for treatment? Radiology. 2009;252:905–913.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhao Y, Li B, et al. Meta-analysis of radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma. BMC Gastroenterol. 2010;10:78.
   PubMed Web of Science ®Google Scholar
• Rim CH, Kim CY, Yang DS, et al. Comparison of radiation therapy modalities for hepatocellular carcinoma with portal vein thrombosis: a meta-analysis and systematic review. Radiother Oncol. 2018;129:112–122.
   PubMed Web of Science ®Google Scholar
• Huang X, Lu S. A meta-analysis comparing the effect of anatomical resection vs. non-anatomical resection on the long-term outcomes for patients undergoing hepatic resection for hepatocellular carcinoma. Hpb. 2017;19:843–849.
   PubMed Web of Science ®Google Scholar
• Hanazawa H, Takahashi S, Shiinoki T, et al. Clinical assessment of coiled fiducial markers as internal surrogates for hepatocellular carcinomas during gated stereotactic body radiotherapy with a real-time tumor-tracking system. Radiother Oncol. 2017;123:43–48.
   PubMed Web of Science ®Google Scholar